Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zach Walsh

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
The International Journal on Drug Policy|June 21, 2014
Barriers to access for Canadians who use cannabis for therapeutic purposesLynne Belle-Isle, Zach Walsh, Robert Callaway, et al.
Journal of Psychopharmacology (Oxford, England)|November 6, 2019
Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of CanadiansStephanie Lake, Thomas Kerr, Jane Buxton, et al.
Plos One|August 29, 2024
"This is you teaching you:" Exploring providers' perspectives on experiential learning and enhancing patient safety and outcomes in ketamine-assisted therapyElena Argento, Tashia Petker, Jayesh Vig, et al.
The International Journal on Drug Policy|July 23, 2023
Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisisHudson Reddon, Stephanie Lake, Maria Eugenia Socias, et al.
Journal of Abnormal Psychology|August 4, 2010
Subtypes of partner violence perpetrators among male and female psychiatric patientsZach Walsh, Marc T Swogger, Brian P O'Connor, et al.
International Journal of Mental Health Nursing|September 28, 2023
Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvementFlorriann Fehr, Lindsay A Lo, Chris Nelson, et al.
Drug and Alcohol Review|September 15, 2015
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factorsPhilippe Lucas, Zach Walsh, Kim Crosby, et al.
Journal of Psychoactive Drugs|October 10, 2023
Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin UseKiffer G Card, Ashmita Grewal, Kalysha Closson, et al.
Journal of Cannabis Research|June 25, 2026
Self-reported cannabis use to manage opioid withdrawal symptoms and reductions in opioid use among people who use unregulated opioids: a cross-sectional analysisErica McAdam, Hudson Reddon, M Eugenia Socías, et al.
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance useZach Walsh, Peter S Hendricks, Stephanie Smith, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
The International Journal on Drug Policy|June 21, 2014
Barriers to access for Canadians who use cannabis for therapeutic purposesLynne Belle-Isle, Zach Walsh, Robert Callaway, et al.
Journal of Psychopharmacology (Oxford, England)|November 6, 2019
Does cannabis use modify the effect of post-traumatic stress disorder on severe depression and suicidal ideation? Evidence from a population-based cross-sectional study of CanadiansStephanie Lake, Thomas Kerr, Jane Buxton, et al.
Plos One|August 29, 2024
"This is you teaching you:" Exploring providers' perspectives on experiential learning and enhancing patient safety and outcomes in ketamine-assisted therapyElena Argento, Tashia Petker, Jayesh Vig, et al.
The International Journal on Drug Policy|July 23, 2023
Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisisHudson Reddon, Stephanie Lake, Maria Eugenia Socias, et al.
Journal of Abnormal Psychology|August 4, 2010
Subtypes of partner violence perpetrators among male and female psychiatric patientsZach Walsh, Marc T Swogger, Brian P O'Connor, et al.
International Journal of Mental Health Nursing|September 28, 2023
Stigma-related barriers to medical cannabis as harm reduction for substance use disorder: Obstacles and opportunities for improvementFlorriann Fehr, Lindsay A Lo, Chris Nelson, et al.
Drug and Alcohol Review|September 15, 2015
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factorsPhilippe Lucas, Zach Walsh, Kim Crosby, et al.
Journal of Psychoactive Drugs|October 10, 2023
Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin UseKiffer G Card, Ashmita Grewal, Kalysha Closson, et al.
Journal of Cannabis Research|June 25, 2026
Self-reported cannabis use to manage opioid withdrawal symptoms and reductions in opioid use among people who use unregulated opioids: a cross-sectional analysisErica McAdam, Hudson Reddon, M Eugenia Socías, et al.
Journal of Psychopharmacology (Oxford, England)|April 22, 2016
Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance useZach Walsh, Peter S Hendricks, Stephanie Smith, et al.
Pageof 9